Injectable Drug Delivery Formulation Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Injectable Drug Delivery Formulation market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Injectable Drug Delivery Formulation market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Injectable Drug Delivery Formulation market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Injectable Drug Delivery Formulation market segmented into
- Conventional Drug Delivery Formulations
- Novel Drug Delivery Formulations
- Long-acting Formulations
- Autoimmune Diseases
- Hormonal Disorders
- Oncology
- Orphan Diseases
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Becton, Dickinson and Company (U.S.)
- Baxter International Inc. (U.S.)
- Gerresheimer AG (Germany)
- Pfizer, Inc. (U.S.)
- Schott AG (Germany)
- Sandoz (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Eli Lilly and Company (U.S.)
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INJECTABLE DRUG DELIVERY FORMULATION INDUSTRY
2.1 Summary about Injectable Drug Delivery Formulation Industry
2.2 Injectable Drug Delivery Formulation Market Trends
2.2.1 Injectable Drug Delivery Formulation Production & Consumption Trends
2.2.2 Injectable Drug Delivery Formulation Demand Structure Trends
2.3 Injectable Drug Delivery Formulation Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Conventional Drug Delivery Formulations
4.2.2 Novel Drug Delivery Formulations
4.2.3 Long-acting Formulations
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Autoimmune Diseases
4.3.2 Hormonal Disorders
4.3.3 Oncology
4.3.4 Orphan Diseases
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Conventional Drug Delivery Formulations
5.2.2 Novel Drug Delivery Formulations
5.2.3 Long-acting Formulations
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Autoimmune Diseases
5.3.2 Hormonal Disorders
5.3.3 Oncology
5.3.4 Orphan Diseases
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Conventional Drug Delivery Formulations
6.2.2 Novel Drug Delivery Formulations
6.2.3 Long-acting Formulations
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Autoimmune Diseases
6.3.2 Hormonal Disorders
6.3.3 Oncology
6.3.4 Orphan Diseases
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Conventional Drug Delivery Formulations
7.2.2 Novel Drug Delivery Formulations
7.2.3 Long-acting Formulations
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Autoimmune Diseases
7.3.2 Hormonal Disorders
7.3.3 Oncology
7.3.4 Orphan Diseases
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Conventional Drug Delivery Formulations
8.2.2 Novel Drug Delivery Formulations
8.2.3 Long-acting Formulations
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Autoimmune Diseases
8.3.2 Hormonal Disorders
8.3.3 Oncology
8.3.4 Orphan Diseases
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Conventional Drug Delivery Formulations
9.2.2 Novel Drug Delivery Formulations
9.2.3 Long-acting Formulations
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Autoimmune Diseases
9.3.2 Hormonal Disorders
9.3.3 Oncology
9.3.4 Orphan Diseases
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Becton, Dickinson and Company (U.S.)
10.1.2 Baxter International Inc. (U.S.)
10.1.3 Gerresheimer AG (Germany)
10.1.4 Pfizer, Inc. (U.S.)
10.1.5 Schott AG (Germany)
10.1.6 Sandoz (Germany)
10.1.7 Teva Pharmaceutical Industries Ltd. (Israel)
10.1.8 Eli Lilly and Company (U.S.)
10.2 Injectable Drug Delivery Formulation Sales Date of Major Players (2017-2020e)
10.2.1 Becton, Dickinson and Company (U.S.)
10.2.2 Baxter International Inc. (U.S.)
10.2.3 Gerresheimer AG (Germany)
10.2.4 Pfizer, Inc. (U.S.)
10.2.5 Schott AG (Germany)
10.2.6 Sandoz (Germany)
10.2.7 Teva Pharmaceutical Industries Ltd. (Israel)
10.2.8 Eli Lilly and Company (U.S.)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INJECTABLE DRUG DELIVERY FORMULATION INDUSTRY
2.1 Summary about Injectable Drug Delivery Formulation Industry
2.2 Injectable Drug Delivery Formulation Market Trends
2.2.1 Injectable Drug Delivery Formulation Production & Consumption Trends
2.2.2 Injectable Drug Delivery Formulation Demand Structure Trends
2.3 Injectable Drug Delivery Formulation Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Conventional Drug Delivery Formulations
4.2.2 Novel Drug Delivery Formulations
4.2.3 Long-acting Formulations
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Autoimmune Diseases
4.3.2 Hormonal Disorders
4.3.3 Oncology
4.3.4 Orphan Diseases
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Conventional Drug Delivery Formulations
5.2.2 Novel Drug Delivery Formulations
5.2.3 Long-acting Formulations
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Autoimmune Diseases
5.3.2 Hormonal Disorders
5.3.3 Oncology
5.3.4 Orphan Diseases
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Conventional Drug Delivery Formulations
6.2.2 Novel Drug Delivery Formulations
6.2.3 Long-acting Formulations
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Autoimmune Diseases
6.3.2 Hormonal Disorders
6.3.3 Oncology
6.3.4 Orphan Diseases
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Conventional Drug Delivery Formulations
7.2.2 Novel Drug Delivery Formulations
7.2.3 Long-acting Formulations
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Autoimmune Diseases
7.3.2 Hormonal Disorders
7.3.3 Oncology
7.3.4 Orphan Diseases
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Conventional Drug Delivery Formulations
8.2.2 Novel Drug Delivery Formulations
8.2.3 Long-acting Formulations
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Autoimmune Diseases
8.3.2 Hormonal Disorders
8.3.3 Oncology
8.3.4 Orphan Diseases
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Conventional Drug Delivery Formulations
9.2.2 Novel Drug Delivery Formulations
9.2.3 Long-acting Formulations
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Autoimmune Diseases
9.3.2 Hormonal Disorders
9.3.3 Oncology
9.3.4 Orphan Diseases
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Becton, Dickinson and Company (U.S.)
10.1.2 Baxter International Inc. (U.S.)
10.1.3 Gerresheimer AG (Germany)
10.1.4 Pfizer, Inc. (U.S.)
10.1.5 Schott AG (Germany)
10.1.6 Sandoz (Germany)
10.1.7 Teva Pharmaceutical Industries Ltd. (Israel)
10.1.8 Eli Lilly and Company (U.S.)
10.2 Injectable Drug Delivery Formulation Sales Date of Major Players (2017-2020e)
10.2.1 Becton, Dickinson and Company (U.S.)
10.2.2 Baxter International Inc. (U.S.)
10.2.3 Gerresheimer AG (Germany)
10.2.4 Pfizer, Inc. (U.S.)
10.2.5 Schott AG (Germany)
10.2.6 Sandoz (Germany)
10.2.7 Teva Pharmaceutical Industries Ltd. (Israel)
10.2.8 Eli Lilly and Company (U.S.)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Injectable Drug Delivery Formulation Product Type Overview
Table Injectable Drug Delivery Formulation Product Type Market Share List
Table Injectable Drug Delivery Formulation Product Type of Major Players
Table Brief Introduction of Becton, Dickinson and Company (U.S.)
Table Brief Introduction of Baxter International Inc. (U.S.)
Table Brief Introduction of Gerresheimer AG (Germany)
Table Brief Introduction of Pfizer, Inc. (U.S.)
Table Brief Introduction of Schott AG (Germany)
Table Brief Introduction of Sandoz (Germany)
Table Brief Introduction of Teva Pharmaceutical Industries Ltd. (Israel)
Table Brief Introduction of Eli Lilly and Company (U.S.)
Table Products & Services of Becton, Dickinson and Company (U.S.)
Table Products & Services of Baxter International Inc. (U.S.)
Table Products & Services of Gerresheimer AG (Germany)
Table Products & Services of Pfizer, Inc. (U.S.)
Table Products & Services of Schott AG (Germany)
Table Products & Services of Sandoz (Germany)
Table Products & Services of Teva Pharmaceutical Industries Ltd. (Israel)
Table Products & Services of Eli Lilly and Company (U.S.)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) by Region 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) Share by Demand 2021f-2026f
Table Injectable Drug Delivery Formulation Product Type Overview
Table Injectable Drug Delivery Formulation Product Type Market Share List
Table Injectable Drug Delivery Formulation Product Type of Major Players
Table Brief Introduction of Becton, Dickinson and Company (U.S.)
Table Brief Introduction of Baxter International Inc. (U.S.)
Table Brief Introduction of Gerresheimer AG (Germany)
Table Brief Introduction of Pfizer, Inc. (U.S.)
Table Brief Introduction of Schott AG (Germany)
Table Brief Introduction of Sandoz (Germany)
Table Brief Introduction of Teva Pharmaceutical Industries Ltd. (Israel)
Table Brief Introduction of Eli Lilly and Company (U.S.)
Table Products & Services of Becton, Dickinson and Company (U.S.)
Table Products & Services of Baxter International Inc. (U.S.)
Table Products & Services of Gerresheimer AG (Germany)
Table Products & Services of Pfizer, Inc. (U.S.)
Table Products & Services of Schott AG (Germany)
Table Products & Services of Sandoz (Germany)
Table Products & Services of Teva Pharmaceutical Industries Ltd. (Israel)
Table Products & Services of Eli Lilly and Company (U.S.)
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) by Region 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Injectable Drug Delivery Formulation Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Injectable Drug Delivery Formulation Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Injectable Drug Delivery Formulation Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Injectable Drug Delivery Formulation Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Becton, Dickinson and Company (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Baxter International Inc. (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Gerresheimer AG (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Pfizer, Inc. (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Schott AG (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Sandoz (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd. (Israel) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Eli Lilly and Company (U.S.) 2017-2020e
Figure Global Injectable Drug Delivery Formulation Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Injectable Drug Delivery Formulation Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Injectable Drug Delivery Formulation Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Injectable Drug Delivery Formulation Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Conventional Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Novel Drug Delivery Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Long-acting Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Orphan Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Becton, Dickinson and Company (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Baxter International Inc. (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Gerresheimer AG (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Pfizer, Inc. (U.S.) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Schott AG (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Sandoz (Germany) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Teva Pharmaceutical Industries Ltd. (Israel) 2017-2020e
Figure Injectable Drug Delivery Formulation Sales Revenue (Million USD) of Eli Lilly and Company (U.S.) 2017-2020e
